39 related articles for article (PubMed ID: 2667525)
1. [Glucose tolerance and electrolyte metabolism in nifedipine and nifedipine dihydroergotoxin treated healthy subjects].
Petersen KG; Ortgiese R; Schuler G; Khalaf N; Schliebs B; Kerp L
Arzneimittelforschung; 1989 May; 39(5):612-4. PubMed ID: 2667525
[TBL] [Abstract][Full Text] [Related]
2. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
3. Insulin and C-peptide responses to 75 g oral glucose load in the healthy man.
Bonora E; Zavaroni I; Alpi O; Pezzarossa A; Bruschi F; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
Diabete Metab; 1986 Jun; 12(3):143-8. PubMed ID: 3525269
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study.
Lind L; Berne C; Pollare T; Lithell H
J Hum Hypertens; 1995 Feb; 9(2):137-41. PubMed ID: 7752176
[TBL] [Abstract][Full Text] [Related]
5. Plasma insulin and C-peptide responses to oral glucose load after physical exercise in men with normal and impaired glucose tolerance.
Nazar K; Kaciuba-Uściłko H; Chwalbińska-Moneta J; Krotkiewski M; Bicz B
Acta Physiol Pol; 1987; 38(6):458-66. PubMed ID: 3331233
[TBL] [Abstract][Full Text] [Related]
6. [Extracardiovascular effects of nifedipine in the treatment of hypertensive patients: glucose tolerance and behavior of immunoreactive insulin].
Vulpis V; Antonacci A; Pirrelli A
Cardiologia; 1988 Feb; 33(2):139-42. PubMed ID: 3282657
[No Abstract] [Full Text] [Related]
7. Coadministration of glyburide and minoxidil, drugs with opposing effects on potassium channels.
Stein CM; Brown N; Carlson MG; Campbell P; Wood AJ
Clin Pharmacol Ther; 1997 Jun; 61(6):662-8. PubMed ID: 9209249
[TBL] [Abstract][Full Text] [Related]
8. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
9. Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.
Hartling SG; Garne S; Binder C; Heilmann C; Petersen W; Petersen KE; Koch C
Diabetes Res; 1988 Apr; 7(4):165-9. PubMed ID: 3042255
[TBL] [Abstract][Full Text] [Related]
10. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
[TBL] [Abstract][Full Text] [Related]
11. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
[TBL] [Abstract][Full Text] [Related]
12. [Influence of insulinfree rehydration on diabetic derangements (author's transl)].
Kleinberger G
Wien Klin Wochenschr; 1980 Sep; 92(17):616-29. PubMed ID: 7006220
[TBL] [Abstract][Full Text] [Related]
13. [Effects of nifedipine on carbohydrate metabolism in the non-insulin dependent diabetic].
Abadie E; Villette JM; Gauville C; Tabuteau F; Fiet J; Passa P
Diabete Metab; 1985 Jun; 11(3):141-6. PubMed ID: 3896885
[TBL] [Abstract][Full Text] [Related]
14. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
[TBL] [Abstract][Full Text] [Related]
15. Impairment of insulin secretion in man by nifedipine.
Giugliano D; Torella R; Cacciapuoti F; Gentile S; Verza M; Varricchio M
Eur J Clin Pharmacol; 1980 Nov; 18(5):395-8. PubMed ID: 7002569
[TBL] [Abstract][Full Text] [Related]
16. Co-dergocrine mesylate inhibits the increase in plasma catecholamines caused by nifedipine in essential hypertension.
Kirsten R; Nelson K; Weidinger G; Welzel D
Eur J Clin Pharmacol; 1990; 39(5):435-9. PubMed ID: 2076734
[TBL] [Abstract][Full Text] [Related]
17. Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients.
Donnelly T; Harrower AD
Curr Med Res Opin; 1980; 6(10):690-3. PubMed ID: 7000443
[TBL] [Abstract][Full Text] [Related]
18. [Effect of nifedipine on the fast phase of insulin secretion stimulated by glucose in the normal male].
Marín PP; Arteaga A; Rodríguez JA
Rev Med Chil; 1984 Sep; 112(9):867-70. PubMed ID: 6398491
[No Abstract] [Full Text] [Related]
19. The effects of flosequinan and nifedipine on glucose tolerance in healthy volunteers.
Lewis H; Kendall M; Bratty JR
J Clin Pharm Ther; 1988 Aug; 13(4):269-72. PubMed ID: 3235476
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycaemic effect of nifedipine.
Charles S; Ketelslegers JM; Buysschaert M; Lambert AE
Br Med J (Clin Res Ed); 1981 Jul; 283(6283):19-20. PubMed ID: 6788246
[No Abstract] [Full Text] [Related]
[Next] [New Search]
